Synchronoss (SNCR) Q2 Earnings and Revenues Miss Estimates

Synchronoss (SNCR) reported Q2 earnings of $0.10 per share, significantly missing the Zacks Consensus Estimate of $0.25 and down from $0.48 a year ago, representing a -60% earnings surprise. Quarterly revenues of $42.49 million also slightly missed estimates and were down year-over-year. This performance continues a pattern of underperformance, with the company missing EPS estimates in three of the last four quarters, contributing to an 18.5% year-to-date stock decline against the S&P 500's 8.6% gain. The unfavorable earnings estimate revisions trend has resulted in a Zacks Rank #4 (Sell) for SNCR, indicating expected near-term market underperformance.

Analysis

Synchronoss (SNCR) reported a significant second-quarter earnings miss, with adjusted EPS of $0.10 falling 60% short of the $0.25 consensus estimate and representing a sharp decline from $0.48 in the prior-year period. This underperformance extends to the top line, as revenues of $42.49 million not only missed estimates but also decreased from $43.46 million a year ago. This result continues a pattern of poor execution, as the company has now missed EPS estimates in three of the last four quarters, including a severe -203.45% surprise in the preceding quarter. The persistent inability to meet expectations has contributed to the stock's substantial year-to-date loss of 18.5%, a stark contrast to the S&P 500's 8.6% gain. The negative outlook is reinforced by a pre-existing unfavorable trend in estimate revisions, which has culminated in a Zacks Rank #4 (Sell), signaling expected near-term market underperformance. While the company operates within the relatively strong Internet - Software industry, which ranks in the top 37% of Zacks industries, its fundamental performance indicates it is failing to capitalize on broader sector strength.

Key Decisions for Investors

• Given the consecutive earnings misses, declining year-over-year revenue, and a Zacks Rank #4 (Sell), investors should exercise extreme caution, and those with existing positions may consider reducing exposure.
• Pay close attention to management's commentary on the upcoming earnings call for any credible explanation for the performance gap and a viable strategy for a turnaround.
• Monitor future analyst estimate revisions closely, as any further downward adjustments to the consensus EPS for upcoming quarters would reinforce the current bearish thesis.